Cellular and Molecular Life Sciences

, Volume 71, Issue 7, pp 1211–1224

Impact of T cell selection methods in the success of clinical adoptive immunotherapy

  • Natalia Ramírez
  • Lorea Beloki
  • Miriam Ciaúrriz
  • Mercedes Rodríguez-Calvillo
  • David Escors
  • Cristina Mansilla
  • Eva Bandrés
  • Eduardo Olavarría
Review

DOI: 10.1007/s00018-013-1463-5

Cite this article as:
Ramírez, N., Beloki, L., Ciaúrriz, M. et al. Cell. Mol. Life Sci. (2014) 71: 1211. doi:10.1007/s00018-013-1463-5

Abstract

Chemotherapy and/or radiotherapy regular regimens used for conditioning of recipients of hematopoietic stem cell transplantation (SCT) induce a period of transient profound immunosuppression. The onset of a competent immunological response, such as the appearance of viral-specific T cells, is associated with a lower incidence of viral infections after haematopoietic transplantation. The rapid development of immunodominant peptide virus screening together with advances in the design of genetic and non-genetic viral- and tumoural-specific cellular selection strategies have opened new strategies for cellular immunotherapy in oncologic recipients who are highly sensitive to viral infections. However, the rapid development of cellular immunotherapy in SCT has disclosed the role of the T cell selection method in the modulation of functional cell activity and of in vivo secondary effects triggered following immunotherapy.

Keywords

Cellular immunotherapyAntigen-specific cytotoxic T cellsCellular functional modulationIn vitro cellular selection methodsHaematopoietic stem cell transplant

Supplementary material

18_2013_1463_MOESM1_ESM.doc (113 kb)
Supplementary material 1 (DOC 113 kb)
18_2013_1463_MOESM2_ESM.doc (124 kb)
Supplementary material 2 (DOC 124 kb)
18_2013_1463_MOESM3_ESM.doc (90 kb)
Supplementary material 3 (DOC 90 kb)
18_2013_1463_MOESM4_ESM.doc (35 kb)
Supplementary material 4 (DOC 35 kb)

Copyright information

© Springer Basel 2013

Authors and Affiliations

  • Natalia Ramírez
    • 1
  • Lorea Beloki
    • 1
  • Miriam Ciaúrriz
    • 1
  • Mercedes Rodríguez-Calvillo
    • 2
  • David Escors
    • 3
  • Cristina Mansilla
    • 1
  • Eva Bandrés
    • 4
  • Eduardo Olavarría
    • 1
    • 2
  1. 1.Oncohematology Research GroupNavarrabiomed, Miguel Servet FoundationPamplonaSpain
  2. 2.Department of HaematologyComplejo Hospitalario de Navarra, Navarra Health ServicePamplonaSpain
  3. 3.Immunomodulation Research GroupNavarrabiomed, Miguel Servet FoundationPamplonaSpain
  4. 4.Immunology UnitComplejo Hospitalario de Navarra, Navarra Health ServicePamplonaSpain